MedTrace Logo

Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.

NCT03766750 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2022-07-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Lima association in the control of type 2 diabetes mellitus

Conditions

  • Type2 Diabetes Mellitus

Interventions

DRUG

LIMA association

1 coated tablet, oral, once a day.

DRUG

Tradjenta

1 coated tablet, oral, once a day.

DRUG

Forxiga

1 coated tablet, oral, once a day.

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2023-10-31
Completion
2023-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03766750 on ClinicalTrials.gov